Fennec Pharmaceuticals, Inc.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 64.29% vs -63.16% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 117.65% vs -109.83% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "20.70",
          "val2": "12.60",
          "chgp": "64.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.10",
          "val2": "-1.20",
          "chgp": "91.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.90",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.30",
          "val2": "-1.70",
          "chgp": "117.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-7.90%",
          "val2": "-92.30%",
          "chgp": "8.44%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -4.15% vs 126.83% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -2,166.67% vs 97.24% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "62.40",
          "val2": "65.10",
          "chgp": "-4.15%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-8.80",
          "val2": "3.50",
          "chgp": "-351.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3.00",
          "val2": "5.70",
          "chgp": "-47.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.80",
          "val2": "-0.10",
          "chgp": "-2,700.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-13.60",
          "val2": "-0.60",
          "chgp": "-2,166.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-140.70%",
          "val2": "54.00%",
          "chgp": "-19.47%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

20.70

12.60

64.29%

Operating Profit (PBDIT) excl Other Income

-0.10

-1.20

91.67%

Interest

0.00

0.90

-100.00%

Exceptional Items

0.00

-0.00

Consolidate Net Profit

0.30

-1.70

117.65%

Operating Profit Margin (Excl OI)

-7.90%

-92.30%

8.44%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 64.29% vs -63.16% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 117.65% vs -109.83% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

62.40

65.10

-4.15%

Operating Profit (PBDIT) excl Other Income

-8.80

3.50

-351.43%

Interest

3.00

5.70

-47.37%

Exceptional Items

-2.80

-0.10

-2,700.00%

Consolidate Net Profit

-13.60

-0.60

-2,166.67%

Operating Profit Margin (Excl OI)

-140.70%

54.00%

-19.47%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -4.15% vs 126.83% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -2,166.67% vs 97.24% in Dec 2024

All Annual Results